Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Guide Adjuvant Therapy in Locally Advanced Upper Tract Urothelial Carcinoma

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2026

Conditions

Muscle Invasive Upper Tract Urothelial Carcinoma

Interventions

DRUG

Adjuvant chemotherapy

cisplatin/carboplatin-gemcitabine 4-6 cycles

DRUG

adjuvant immunotherapy

immunotherapy for one year

Trial Locations (1)

RECRUITING

Renji Hospital, Shanghai

All Listed Sponsors

collaborator

West China Hospital

OTHER

lead

RenJi Hospital

OTHER